Antibacterial effects and physical properties of glass-ionomer cements containing chlorhexidine for the ART approach.
OBJECTIVE
Since atraumatic restorative treatment (ART) involves removal of carious lesions with manual instruments, improvement of filling materials to guarantee greater success should be considered. This study aimed to evaluate antibacterial, physical, and bonding properties of glass-ionomer cements (GIC) containing chlorhexidine (CHX), and to determine optimal concentrations for incorporation of agents to obtain antibacterial GICs for use with the ART approach.


METHODS
CHX diacetate combined with CHX dihydrochloride was added to control GIC powder to obtain concentration ratios of 1/0, 2/0, 3/0, 1/1, or 2/2% w/w. Antibacterial activity of each cement against Streptococcus mutans, Lactobacillus casei or Actinomyces naeslundii was examined using agar-diffusion methods, and release of CHX was analyzed by HPLC. Compressive strength, bond strength to dentin, and setting time were measured, and compared with those of control samples.


RESULTS
All experimental GICs exhibited inhibition of three bacteria, but sizes of inhibition zones and concentrations of CHX released were not dependent upon CHX content. Incorporation of CHX diacetate at 2% or greater, significantly decreased compressive strength, and bond strength to dentin was adversely affected by addition of CHX diacetate at 2% or more (p<0.05, ANOVA, Fisher's PLSD test), although setting time was extended a little by addition of any concentrations of CHX.


CONCLUSIONS
The present results demonstrate that experimental GICs containing CHX are effective in inhibiting bacteria associated with caries, and incorporation of 1% CHX diacetate is optimal to give appropriate physical and bonding properties.
Takahashi
Yusuke
Y
Department of Restorative Dentistry and Endodontology, Osaka University Graduate School of Dentistry, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan.
Imazato
Satoshi
S
Kaneshiro
Andrea V
AV
Ebisu
Shigeyuki
S
Frencken
Jo E
JE
Tay
Franklin R
FR
D000190:Actinomyces / Q000187:drug effects; D000704:Analysis of Variance; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage* / Q000494:pharmacology; D016009:Chi-Square Distribution; D002710:Chlorhexidine / Q000008:administration & dosage* / Q000494:pharmacology; D019245:Compressive Strength; D001840:Dental Bonding; D003793:Dental Restoration, Permanent / Q000379:methods*; D003799:Dental Stress Analysis; D017220:Dentin-Bonding Agents / Q000494:pharmacology; D005899:Glass Ionomer Cements / Q000494:pharmacology; D007780:Lacticaseibacillus casei / Q000187:drug effects; D019060:Minimally Invasive Surgical Procedures; D013295:Streptococcus mutans / Q000187:drug effects
D000891:Anti-Infective Agents, Local; D017220:Dentin-Bonding Agents; D005899:Glass Ionomer Cements; D002710:Chlorhexidine